Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Hayden

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Chemical Research in Toxicology|March 1, 1992
Formation of mitochondrial phospholipid adducts by nephrotoxic cysteine conjugate metabolitesP J Hayden, C J Welsh, Y Yang, et al.
Biochemistry|June 18, 1991
Formation of difluorothionoacetyl-protein adducts by S-(1,1,2,2-tetrafluoroethyl)-L-cysteine metabolites: nucleophilic catalysis of stable lysyl adduct formation by histidine and tyrosineP J Hayden, Y Yang, A J Ward, et al.
International Journal of Laboratory Hematology|February 9, 2012
Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotypeS E Langabeer, D O'Brien, S Liptrot, et al.
Chemical Research in Toxicology|March 1, 1993
Formation, characterization, and immunoreactivity of lysine thioamide adducts from fluorinated nephrotoxic cysteine conjugates in vitro and in vivoM B Fisher, P J Hayden, S A Bruschi, et al.
Bone Marrow Transplantation|September 3, 2004
A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phaseP J Hayden, F Keogh, M Ni Conghaile, et al.
European Journal of Haematology|February 3, 2006
Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donorD O'Donghaile, P J Hayden, S L McCarron, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2016
Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathyM Lavin, T M Brophy, O Rawley, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 31, 2010
Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skinT Hu, Z S Khambatta, P J Hayden, et al.
Bone Marrow Transplantation|March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USAK W Douglas, A N Parker, P J Hayden, et al.
Irish Journal of Medical Science|August 13, 2005
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003P J Hayden, A O'Driscoll, N Gardiner, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chemical Research in Toxicology|March 1, 1992
Formation of mitochondrial phospholipid adducts by nephrotoxic cysteine conjugate metabolitesP J Hayden, C J Welsh, Y Yang, et al.
Biochemistry|June 18, 1991
Formation of difluorothionoacetyl-protein adducts by S-(1,1,2,2-tetrafluoroethyl)-L-cysteine metabolites: nucleophilic catalysis of stable lysyl adduct formation by histidine and tyrosineP J Hayden, Y Yang, A J Ward, et al.
International Journal of Laboratory Hematology|February 9, 2012
Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotypeS E Langabeer, D O'Brien, S Liptrot, et al.
Chemical Research in Toxicology|March 1, 1993
Formation, characterization, and immunoreactivity of lysine thioamide adducts from fluorinated nephrotoxic cysteine conjugates in vitro and in vivoM B Fisher, P J Hayden, S A Bruschi, et al.
Bone Marrow Transplantation|September 3, 2004
A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phaseP J Hayden, F Keogh, M Ni Conghaile, et al.
European Journal of Haematology|February 3, 2006
Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donorD O'Donghaile, P J Hayden, S L McCarron, et al.
Journal of Thrombosis and Haemostasis : JTH|March 19, 2016
Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathyM Lavin, T M Brophy, O Rawley, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 31, 2010
Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skinT Hu, Z S Khambatta, P J Hayden, et al.
Bone Marrow Transplantation|March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USAK W Douglas, A N Parker, P J Hayden, et al.
Irish Journal of Medical Science|August 13, 2005
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003P J Hayden, A O'Driscoll, N Gardiner, et al.
Pageof 3